| 摘要 |
<p>The present invention relates to a reading that myricetin acts as an effective inhibitor of serotonin N-acetyltransferase, and a pharmaceutical composition for treating a serotonin N-acetyltransferase-associated disease which comprises myricetin as an active ingredient. The pharmaceutical composition of the present invention is particularly useful for treating sleep-disorder, depression, stress-related diseases or obesity.</p> |
